Please Wait.....
Report
Europe Immunodiagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Product [Enzyme-Linked Immunosorbent Assays (ELISA), Chemiluminescence Immunoassays (CLIA), Radioimmunoassays (RIA), and Others], Clinical Indication (Infectious Diseases, Hepatitis+HIV, Endocrinology, Gastrointestinal, Metabolics, and Others), and End User (Hospitals, Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others)
Market Report I 2023-01-18 I 222 Pages I The Insight Partners
The Europe immunodiagnostics market is expected to grow from US$ 5,734.92 million in 2022 to US$ 8,686.76 million by 2028; it is estimated to grow at a CAGR of 7.2% from 2022 to 2028.
Increasing Use of Point-of-Care Immunodiagnostics Drives Europe Immunodiagnostics Market Growth
Point-of-care testing (POCT) has become critical to patient-centric healthcare due to the need for rapid diagnostic results to determine the accurate and faster treatment. A shift from centralized point-of-care testing to decentralized testing for chronic and infectious patients has resulted in convenient patient access to these diagnostics. The current approach to diagnose and monitor chronic conditions or detect pathogens such as bacteria and viruses is immunoassay testing. Advanced point-of-care devices enable rapid screening of up to three components from a single sample. Also, the point-of-care diagnostics (POCD) inclined toward mobile healthcare (mH) smart devices could revolutionize personalized healthcare monitoring and management, paving the way for next-generation POCTs. Infectious disease management can be significantly improved by POCTs, especially in developing countries where access to timely medical care is challenging and healthcare infrastructure is outdated and sparse. Additionally, the technologically developed diagnostic kits lead to fewer manual errors. Innovative immunodiagnostic products are being developed by several market players. For instance, Thermo Fisher Scientific has developed immunodiagnostic products such as enzyme-linked immunoassay (ELISA) reagents and buffers, antibodies and detection probes, linking mechanisms, blocking buffers and detergents, detection substrates, and capture surfaces, as well as services such as bioconjugation and detection. Further, on September 1, 2020, Roche launched SARS-CoV-2 Rapid Antigen Test. The test is used in POC settings for symptomatic and asymptomatic people to help healthcare professionals identify the infection within 15 minutes in people suspected of carrying SARS-CoV-2. Likewise, the use of immunodiagnostics in cancer treatment is also increasing. In oncology, an immunodiagnostic test can confirm the presence of a solid tumor by detecting known tumor-associated antigens or antibodies. These advantages and indications are a few factors driving the Europe immunodiagnostics market .
Europe Immunodiagnostics Market Growth Overview
The Europe immunodiagnostic market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. The market growth in the region is characterized by the high prevalence of chronic diseases in major European countries, a surge in demand for effective immunoassay analyzers, and the introduction of technologically advanced analyzers. For instance, in December 2019, Eurofins Abraxis-a biotechnology company-launched an automated ELISA Analyzer, CAAS Cube-a single plate data analysis system-to facilitate enhanced data analysis and customize settings to accommodate laboratory testing requirements. The German immunodiagnostic market has been witnessing substantial growth due to its supportive healthcare policies and the presence of a huge geriatric population. According to the UN population data, 1 out of every 20 Germans is aged above 80 years, and the number is expected to reach 6 out of every 20 people by 2050. The risk of developing chronic diseases, such as cardiovascular diseases (CVDs), diabetes, and neurovascular disorders, increases with age. According to World Cancer Research Fund, in the UK, 387,820 people were diagnosed with cancer in 2019. The most common types of cancer in Germany are breast cancer, prostate cancer, colorectum (large bowel) cancer, lung cancer, and bladder cancer. These five cancer types accounted for ~57% of all new cancer diagnoses in Germany. Therefore, the rising prevalence of cancer in the country leads to a growing demand for disease diagnostics.
Europe Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
Europe Immunodiagnostics Market Segmentation
The Europe immunodiagnostics market is segmented based on product, clinical indication, end user, and country.
Based on product, the Europe immunodiagnostics market is segmented into enzyme-linked immunosorbent assays (ELISA), chemiluminescence immunoassays (CLIA), radioimmunoassay (RIA), and others. The enzyme-linked immunosorbent assays (ELISA) segment registered the largest share of the market in 2022.
Based on clinical indication, the Europe immunodiagnostics market is segmented into infectious diseases, hepatitis+HIV, endocrinology, gastrointestinal, metabolics and others. The infectious diseases segment registered the largest share of the market in 2022.
Based on end user, the Europe immunodiagnostics market is segmented into hospitals, clinics, diagnostics laboratories, academic and research institutes, and others. The hospital segment registered the largest share of the market in 2022.
Based on country, the Europe immunodiagnostics market is segmented into Germany, France, Italy, the UK, Spain, and the Rest of Europe. Germany dominated the market in 2022.
Abbott Laboratories; bioMerieux SA; Danaher Corp; DiaSorin S.p.A.; F. Hoffmann-La Roche Ltd; PerkinElmer Inc.; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; Siemens Healthineers AG; Svar Life Science AB; and Thermo Fisher Scientific Inc are the leading companies operating in the Europe immunodiagnostics market.
TABLE OF CONTENTS
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Immunodiagnostics Market - By Product
1.3.2 Europe Immunodiagnostics Market - By Clinical Indication
1.3.3 Europe Immunodiagnostics Market - By End User
1.3.4 Europe Immunodiagnostics Market- By Country
2. Europe Immunodiagnostics Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Immunodiagnostics Market- Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Experts Opinion
5. Europe Immunodiagnostics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Infectious Diseases
5.1.2 Growing Use of Point-of-Care Immunodiagnostics
5.2 Market Restraints
5.2.1 Inadequate Reimbursement Scenario
5.3 Market Opportunities
5.3.1 Rising Focus on R&D Investment and Expansion by Key Players
5.4 Future Trends
5.4.1 Technological Advancements in Immunodiagnostics
5.5 Impact Analysis
6. Immunodiagnostics Market- Europe Analysis
6.1 Europe Immunodiagnostics Market Revenue Forecast and Analysis
7. Europe Immunodiagnostics Market Analysis - by Product
7.1 Overview
7.2 Europe Immunodiagnostics Market, By Product, 2021 & 2028 (%)
7.3 Enzyme-linked immunosorbent assays (ELISA)
7.3.1 Overview
7.3.2 Enzyme-linked immunosorbent assays (ELISA): Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Chemiluminescence immunoassays (CLIA)
7.4.1 Overview
7.4.2 Chemiluminescence immunoassays (CLIA): Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4.3 Vitamin D Assay
7.4.3.1 Overview
7.4.3.2 Vitamin D Assay: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4.4 HIV Detection
7.4.4.1 Overview
7.4.4.2 HIV Detection: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4.5 HIV Ag/Ab Combo assay
7.4.5.1 Overview
7.4.5.2 HIV Ag/Ab Combo assay: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4.6 Other Tests
7.4.6.1 Overview
7.4.6.2 Other Tests: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Radioimmunoassays (RIA)
7.5.1 Overview
7.5.2 Radioimmunoassays (RIA): Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
8. Europe Immunodiagnostics Market Analysis - Clinical Indication
8.1 Overview
8.2 Europe Immunodiagnostics Market Share by Clinical Indication - 2021 & 2028 (%)
8.3 Infectious Diseases:
8.3.1 Overview
8.3.2 Infectious Diseases: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.3 COVID-19
8.3.3.1 Overview
8.3.3.2 COVID-19: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.4 Tuberculosis
8.3.4.1 Overview
8.3.4.2 Tuberculosis: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.5 Lyme
8.3.5.1 Overview
8.3.5.2 Lyme: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.6 Infection Management
8.3.6.1 Overview
8.3.6.2 Infection Management: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.7 Zika
8.3.7.1 Overview
8.3.7.2 Zika: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.8 Treponema
8.3.8.1 Overview
8.3.8.2 Treponema: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.9 TORCH
8.3.9.1 Overview
8.3.9.2 TORCH: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.10 Measles and Mumps
8.3.10.1 Overview
8.3.10.2 Measles and Mumps: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.11 VZV
8.3.11.1 Overview
8.3.11.2 VZV: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.12 EBV
8.3.12.1 Overview
8.3.12.2 EBV: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.4 Hepatitis+HIV:
8.4.1 Overview
8.4.2 Hepatitis+HIV: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.5 Gastrointestinal
8.5.1 Overview
8.5.2 Gastrointestinal: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.6 Metabolics
8.6.1 Overview
8.6.2 Metabolics: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7 Endocrinology
8.7.1 Overview
8.7.2 Endocrinology: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7.3 Hypertension
8.7.3.1 Overview
8.7.3.2 Hypertension: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7.4 Growth
8.7.4.1 Overview
8.7.4.2 Growth: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7.5 Diabetes
8.7.5.1 Overview
8.7.5.2 Diabetes: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7.6 Thyroid
8.7.6.1 Overview
8.7.6.2 Thyroid: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7.7 Reproductive Endocrinology
8.7.7.1 Overview
8.7.7.2 Reproductive endocrinology: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
9. Europe Immunodiagnostics Market Analysis - End User
9.1 Overview
9.2 Europe Immunodiagnostics Market Share by End User - 2021 & 2028 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.5 Diagnostic Laboratories
9.5.1 Overview
9.5.2 Diagnostic Laboratories: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.6 Academic and Research Institutes
9.6.1 Overview
9.6.2 Academic and Research Institutes: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)
10. Europe Immunodiagnostics Market Revenue and Forecast to 2028- by Country
10.1 Overview
10.1.1 Europe: Immunodiagnostics Market, by Country, 2021 & 2028 (%)
10.1.1.1 Germany: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.1.1.1 Germany: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.1.1.2 Germany Immunodiagnostics Market, by Product - Revenue and Forecast to 2028 (USD Million)
10.1.1.1.2.1 Germany Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2028 (USD Million)
10.1.1.1.3 Germany Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2028 (USD Million)
10.1.1.1.3.1 Germany Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2028 (USD Million)
10.1.1.1.3.2 Germany Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2028 (USD Million)
10.1.1.1.4 Germany: Immunodiagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.1.1.2 France: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.1.2.1 France: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.1.2.2 France Immunodiagnostics Market, by Product - Revenue and Forecast to 2028 (USD Million)
10.1.1.2.2.1 France Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) - Revenue and Forecast to 2028 (USD Million)
10.1.1.2.3 France Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2028 (USD Million)
10.1.1.2.3.1 France Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2028 (USD Million)
10.1.1.2.3.2 France Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2028 (USD Million)
10.1.1.2.4 France Immunodiagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.1.1.3 UK: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.1.3.1 UK: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.1.3.2 UK Immunodiagnostics Market, by Product - Revenue and Forecast to 2028 (USD Million)
10.1.1.3.2.1 UK Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) - Revenue and Forecast to 2028 (USD Million)
10.1.1.3.3 UK Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2028 (USD Million)
10.1.1.3.3.1 UK Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2028 (USD Million)
10.1.1.3.3.2 UK Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2028 (USD Million)
10.1.1.3.4 UK Immunodiagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.1.1.4 Italy: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.1.4.1 Italy: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.1.4.2 Italy Immunodiagnostics Market, by Product - Revenue and Forecast to 2028 (USD Million)
10.1.1.4.2.1 Italy Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) - Revenue and Forecast to 2028 (USD Million)
10.1.1.4.3 Italy Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2028 (USD Million)
10.1.1.4.3.1 Italy Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2028 (USD Million)
10.1.1.4.3.2 Italy Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2028 (USD Million)
10.1.1.4.4 Italy Immunodiagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.1.1.5 Spain: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.1.5.1 Spain: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.1.5.2 Spain Immunodiagnostics Market, by Product - Revenue and Forecast to 2028 (USD Million)
10.1.1.5.2.1 Spain Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) - Revenue and Forecast to 2028 (USD Million)
10.1.1.5.3 Spain Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2028 (USD Million)
10.1.1.5.3.1 Spain Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2028 (USD Million)
10.1.1.5.3.2 Spain Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2028 (USD Million)
10.1.1.5.4 Spain Immunodiagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.1.1.6 Rest of Europe: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.1.6.1 Rest of Europe: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.1.6.2 Rest of Europe Immunodiagnostics Market, by Product - Revenue and Forecast to 2028 (USD Million)
10.1.1.6.2.1 Rest of Europe Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) - Revenue and Forecast to 2028 (USD Million)
10.1.1.6.3 Rest of Europe Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2028 (USD Million)
10.1.1.6.3.1 Rest of Europe Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2028 (USD Million)
10.1.1.6.3.2 Rest of Europe Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2028 (USD Million)
10.1.1.6.4 Rest of Europe Immunodiagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11. Europe Immunodiagnostics Market -Industry Landscape
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 DiaSorin S.p.A.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Danaher Corp
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Thermo Fisher Scientific Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 PerkinElmer Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 bioMerieux SA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Svar Life Science AB
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Siemens Healthineers AG
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe Immunodiagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany Immunodiagnostics Market, by Product - Revenue and Forecast to 2028 (USD Million)
Table 3. Germany Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2028 (USD Million)
Table 4. Germany Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2028 (USD Million)
Table 5. Germany Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2028 (USD Million)
Table 6. Germany Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2028 (USD Million)
Table 7. Germany Immunodiagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)
Table 8. France Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)
Table 9. France Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)
Table 10. France Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2028 (USD Million)
Table 11. France Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2028 (USD Million)
Table 12. France Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2028 (USD Million)
Table 13. France Immunodiagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 14. UK Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)
Table 15. UK Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)
Table 16. UK Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2028 (USD Million)
Table 17. UK Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2028 (USD Million)
Table 18. UK Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2028 (USD Million)
Table 19. UK Immunodiagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 20. Italy Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)
Table 21. Italy Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)
Table 22. Italy Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2028 (USD Million)
Table 23. Italy Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2028 (USD Million)
Table 24. Italy Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2028 (USD Million)
Table 25. Italy Immunodiagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 26. Spain Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)
Table 27. Spain Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)
Table 28. Spain Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2028 (USD Million)
Table 29. Spain Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2028 (USD Million)
Table 30. Spain Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2028 (USD Million)
Table 31. Spain Immunodiagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 32. Rest of Europe Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)
Table 33. Rest of Europe Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)
Table 34. Rest of Europe Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2028 (USD Million)
Table 35. Rest of Europe Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2028 (USD Million)
Table 36. Rest of Europe Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2028 (USD Million)
Table 37. Rest of Europe Immunodiagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 38. Recent Inorganic Growth Strategies in the Immunodiagnostics Market
Table 39. Recent Organic Growth Strategies in the Immunodiagnostics Market
Table 40. Glossary of Terms, Immunodiagnostics Market
LIST OF FIGURES
Figure 1. Europe Immunodiagnostics Market Segmentation
Figure 2. Europe Immunodiagnostics Market Segmentation, By Country
Figure 3. Europe Immunodiagnostics Market Overview
Figure 4. Europe Immunodiagnostics Market, by Product
Figure 5. Europe Immunodiagnostics Market, by Country
Figure 6. Europe PEST Analysis
Figure 7. Europe Immunodiagnostics Market: Impact Analysis of Drivers and Restraints
Figure 8. Europe Immunodiagnostics Market- Revenue Forecast and Analysis - 2020 - 2028
Figure 9. Europe Immunodiagnostics Market, by Product, 2021 & 2028 (%)
Figure 10. Enzyme-linked immunosorbent assays (ELISA): Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 11. Chemiluminescence immunoassays (CLIA): Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. Vitamin D Assay: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. HIV Detection: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. HIV Ag/Ab Combo assay: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. Other Tests: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16. Radioimmunoassays (RIA): Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17. Others: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. Europe Immunodiagnostics Market Share by Clinical Indication - 2021 & 2028 (%)
Figure 19. Infectious Diseases: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 20. COVID-19: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Tuberculosis: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. Lyme: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. Infection Management: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. Zika: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. Treponema: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 26. TORCH: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 27. Measles and Mumps: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 28. VZV: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 29. EBV: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 30. Hepatitis+HIV: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 31. Gastrointestinal: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 32. Metabolics: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 33. Endocrinology: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 34. Hypertension: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 35. Growth: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 36. Diabetes: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 37. Thyroid: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 38. Reproductive endocrinology: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 39. Others: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 40. Europe Immunodiagnostics Market Share by End User - 2021 & 2028 (%)
Figure 41. Hospitals: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 42. Clinics: Europe Immunodiagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 43. Diagnostic Laboratories: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 44. Academic and Research Institutes: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 45. Others: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 46. Europe: Immunodiagnostics Market, by Key Country - Revenue (2021) (USD Million)
Figure 47. Europe: Immunodiagnostics Market, by Country, 2021 & 2028 (%)
Figure 48. Germany: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 49. France: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 50. UK: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 51. Italy: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 52. Spain: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 53. Rest of Europe: Immunodiagnostics Market - Revenue and Forecast to 2028 (USD Million)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security